MedPath

Resistance Exercise Training in Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Registration Number
NCT03120416
Lead Sponsor
University of Illinois at Chicago
Brief Summary

The investigators aim to evaluate the feasibility of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function.

Detailed Description

Resistance exercise training has been shown to improve cardiovascular health including endothelial function in general populations, but studies in patients with chronic kidney disease (CKD) are limited. The investigators aim to evaluate the feasibility and acceptability of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function as measured by brachial artery flow-mediated dilation, pulse-wave velocity and carotid artery stiffness. To accomplish this goal the investigators propose to conduct a 12-week pilot randomized controlled trial of twice a week resistance exercise training among 32 adults with CKD. The results of this study will inform the design and implementation of a larger trial evaluating the impact of resistance exercise training on adverse outcomes in patients with CKD including CKD progression.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • CKD stage 3 or 4 (eGFR 15-60 ml/min/1.73m2)
Exclusion Criteria
  • Currently institutionalized
  • Kidney transplant or dialysis
  • NY Heart Association class 3-4 heart failure
  • Dementia or cognitive impairment
  • Unstable angina or coronary revascularization within the last 3 months
  • Uncontrolled arrhythmia
  • Severe chronic lung disease
  • Orthopedic, neurologic or other condition that would preclude resistance exercise training
  • Pregnancy
  • Uncontrolled hypertension (systolic > 160 mmHg and diastolic >90 mmHg)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Endothelial function3 months

Measured by brachial artery flow-mediated dilation (FMD)

Secondary Outcome Measures
NameTimeMethod
Objectively measured physical activity3 months

Assessed by a physical activity monitor (ActiGraph GT3X+)

Serum LDL-cholesterol3 months

Measured using standard procedures

Vascular function3 months

Measured by pulse wave velocity

Carotid artery stiffness3 months

Measured by non-invasive ultrasound

Systolic blood pressure3 months

Measured using standard procedures

Muscle strength3 months

Assessed by the amount of weight lifted in a single chest press and leg press (1 RM).

Self-reported physical activity3 months

Assessed by the MESA (Multiethnic Study of Atherosclerosis) Typical Week Physical Activity Survey

Serum HDL-cholesterol3 months

Measured using standard procedures

Trial Locations

Locations (1)

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

University of Illinois at Chicago
🇺🇸Chicago, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.